Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
58.46 USD | +0.79% | +4.99% | -14.43% |
Sales 2024 * | 230M 287M 23.92B | Sales 2025 * | 244M 305M 25.43B | Capitalization | 2.37B 2.96B 247B |
---|---|---|---|---|---|
Net income 2024 * | -71M -88.69M -7.39B | Net income 2025 * | -90M -112M -9.37B | EV / Sales 2024 * | 9.04 x |
Net cash position 2024 * | 293M 366M 30.5B | Net cash position 2025 * | 219M 274M 22.82B | EV / Sales 2025 * | 8.81 x |
P/E ratio 2024 * |
-37.7
x | P/E ratio 2025 * |
-26.7
x | Employees | 497 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 45.6% |
Latest transcript on Immunocore Holdings plc
1 day | +0.79% | ||
1 week | +4.99% | ||
Current month | -10.06% | ||
1 month | -5.19% | ||
3 months | -16.46% | ||
6 months | +27.34% | ||
Current year | -14.43% |
Managers | Title | Age | Since |
---|---|---|---|
Bahija Jallal
CEO | Chief Executive Officer | 62 | 01/19/01 |
Brian DiDonato
DFI | Director of Finance/CFO | 57 | 01/20/01 |
John Trainer
COO | Chief Operating Officer | 50 | 01/23/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Perez
BRD | Director/Board Member | 59 | 01/19/01 |
John Bell
CHM | Chairman | 71 | 01/15/01 |
Bahija Jallal
CEO | Chief Executive Officer | 62 | 01/19/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 1,026 M€ | +6.95% | - | |
0.18% | 0 M€ | 0.00% | - | |
0.14% | 5 M€ | +8.63% |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 58.46 | +0.79% | 403,551 |
25/24/25 | 58 | -0.80% | 496,622 |
24/24/24 | 58.47 | +2.02% | 394,870 |
23/24/23 | 57.31 | +2.67% | 302,166 |
22/24/22 | 55.82 | +0.25% | 295,838 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.43% | 2.95B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- IMCR Stock